Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Economic Imperatives and Ethical Values in Global Business by

bigCover of the book The gm/ID Methodology, a sizing tool for low-voltage analog CMOS Circuits by

bigCover of the book Male and Female Circumcision by

bigCover of the book Breast Cancer: Scientific and Clinical Progress by

bigCover of the book Thyroid Cytopathology by

bigCover of the book Bio-Medical CMOS ICs by

bigCover of the book Globalization, Growth and Sustainability by

bigCover of the book Linear Programming by

bigCover of the book fMRI: From Nuclear Spins to Brain Functions by

bigCover of the book Creating Wholeness by

bigCover of the book Cancer Immunology: Innovative Approaches to Therapy by

bigCover of the book International Handbook of Adolescent Pregnancy by

bigCover of the book Acute Coronary Care 1987 by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy